Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04300647
Title A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer (SKYSCRAPER-04)
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma



Atezolizumab + Tiragolumab

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | CAN

No variant requirements are available.